Incremental dose-response effect of age on mortality in non-seminoma testis cancer patients

Reha-Baris Incesu; Mattia Luca Piccinelli; Simone Morra; Lukas Scheipner; S Tappero; Francesco Barletta; Cristina Cano Garcia; Zhe Tian; Fred Saad; Shahrokh F. Shariat; Felix KH Chun; Alberto Briganti; L. Tralce; Sascha Ahyai; Nicola Longo; Ottavio de Cobelli; Derya Tilki; Markus Graefen; Pierre I. Karakiewicz

doi:10.1016/j.urolonc.2026.110991

Key Points

Mortality rates increase incrementally with age in patients with non-seminoma testis cancer, highlighting a crucial link between age and health outcomes.
A dose-response relationship is observed; specifically, older patients show significantly higher mortality than younger counterparts.
Analysis was conducted on a large dataset of non-seminoma testis cancer cases, examining age impacts on mortality risk.
Findings underscore the need for age-specific treatment strategies in managing non-seminoma testis cancer effectively.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Observational analysis uncovers an age-related mortality increase in non-seminoma testis cancer, suggesting critical implications for treatment strategies.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Incesu et al. (2026) studied this question.

synapsesocial.com/papers/69a767b7badf0bb9e87e20d7 https://doi.org/10.1016/j.urolonc.2026.110991

View at Publisher

Ask AI

Bookmark

Share

Incremental dose-response effect of age on mortality in non-seminoma testis cancer patients

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Incremental dose-response effect of age on mortality in non-seminoma testis cancer patients

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

Keep reading